U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806488) titled 'Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas' on Dec. 03, 2024.
Brief Summary: This is a purely retrospective and observational monocentric study
Study Start Date: May, 2025
Study Type: OBSERVATIONAL
Condition:
Marginal Zone B Cell Lymphoma
Recruitment Status: RECRUITING
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Published by HT Digital Content Services with permission from Health Daily Digest....